Physician profile
Aron Hughes
NPI 1477934206
$2,070.35
in general payments reported to CMS, 2019-2025
14 companies · $750 in 2025
The $750 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.63 · 2020: $51.82 · 2021: $337 · 2022: $226 · 2023: $301 · 2024: $359 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889 · Consulting Fee: $500 · Entertainment: $20.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.34 |
| Consulting Fee | $500.00 |
| Entertainment | $20.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $992.24 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $406.07 | 2021-2025 | Total30, Precision7 |
| Ocular Therapeutix, INC. | $138.07 | 2024 | Dextenza |
| Glaukos Corporation | $131.62 | 2021 | |
| Oyster Point Pharma, INC. | $107.74 | 2022-2024 | Ryzumvi, Tyrvaya |
| Novartis Pharmaceuticals Corporation | $101.45 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $53.65 | 2022-2024 | Zylet, Miebo, Vyzulta |
| Allergan, INC. | $31.99 | 2022 | |
| Abbvie INC. | $28.75 | 2022 | |
| Optos, INC. | $20.68 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $20.00 | 2021 | |
| Aerie Pharmaceuticals, INC. | $16.31 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.23 | 2019 | |
| Maculogix, INC. | $5.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aron Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.